Nordea Investment Management
RARE icon

Nordea Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Nordea Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57,939
Closed -$1.2M – 956
2026
Q1 		$1.2M Sell
57,939
-899
-2% -$20.2K ﹤0.01% 811
2025
Q4 		$1.32M Sell
58,838
-6,899
-10% -$227K ﹤0.01% 811
2025
Q3 		$1.97M Buy
65,737
+5,561
+9% +$167K ﹤0.01% 745
2025
Q2 		$2.21M Buy
60,176
+22,509
+60% +$811K ﹤0.01% 714
2025
Q1 		$1.37M Sell
37,667
-2,006
-5% -$83.5K ﹤0.01% 760
2024
Q4 		$1.66M Buy
39,673
+3,246
+9% +$161K ﹤0.01% 714
2024
Q3 		$2.03M Sell
36,427
-1,386
-4% -$70.6K ﹤0.01% 687
2024
Q2 		$1.55M Sell
37,813
-7,230
-16% -$309K ﹤0.01% 737
2024
Q1 		$2.11M Sell
45,043
-422
-0.9% -$19.9K ﹤0.01% 702
2023
Q4 		$2.17M Sell
45,465
-921
-2% -$35.7K ﹤0.01% 691
2023
Q3 		$1.67M Buy
46,386
+49
+0.1% +$1.94K ﹤0.01% 726
2023
Q2 		$2.19M Buy
46,337
+27,569
+147% +$1.28M ﹤0.01% 679
2023
Q1 		$734K Sell
18,768
-754
-4% -$32.4K ﹤0.01% 845
2022
Q4 		$894K Buy
19,522
+537
+3% +$21.1K ﹤0.01% 792
2022
Q3 		$810K Sell
18,985
-1,232
-6% -$63.3K ﹤0.01% 811
2022
Q2 		$1.2M Buy
20,217
+11,066
+121% +$681K ﹤0.01% 758
2022
Q1 		$660K Buy
9,151
+1,459
+19% +$102K ﹤0.01% 864
2021
Q4 		$656K Hold
7,692
– – ﹤0.01% 881
2021
Q3 		$674K Hold
7,692
– – ﹤0.01% 883
2021
Q2 		$733K Buy
7,692
+728
+10% +$75.8K ﹤0.01% 858
2021
Q1 		$800K Buy
+6,964
New +$948K ﹤0.01% 809

Other funds holding RARE

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Nordea Investment Management's RARE Position: Q2 2026 in Review

Nordea Investment Management sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 57,939 shares — an estimated $1.2M sold.

Nordea Investment Management first reported a position in RARE in Q1 2021 and held it in 21 quarters. The position peaked at $2.21M in Q2 2025. 80 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Nordea Investment Management reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Nordea Investment Management sold 57,939 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.2M.
  • Nordea Investment Management first reported a position in Ultragenyx Pharmaceutical in Q1 2021 and held it in 21 quarters.
  • Nordea Investment Management's Ultragenyx Pharmaceutical position peaked at $2.21M in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.